New drug shows promise for managing short bowel syndrome long-term

NCT ID NCT03905707

First seen Feb 02, 2026 · Last updated May 14, 2026 · Updated 14 times

Summary

This study tests the long-term safety of glepaglutide, a medicine for people with short bowel syndrome (SBS). SBS makes it hard for the body to absorb nutrients from food. The trial involves 145 adults who have already taken part in earlier studies. Researchers will track side effects and changes in blood pressure over time to see if the drug is safe for ongoing use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Asklepios Kliniken Hamburg GmbH

    Hamburg, Germany

  • Centre Hospitalier Lyon-Sud

    Pierre-Bénite, France

  • Charité - Universitätsmedizin Berlin

    Berlin, Germany

  • Cleveland Clinic

    Cleveland, Ohio, 44195, United States

  • Georgetown University Medical Center

    Washington D.C., District of Columbia, 20007, United States

  • Hôpital Beaujon

    Clichy, France

  • Mayo Clinic College of Medicine

    Rochester, Minnesota, 55905, United States

  • Mount Sinai Hospital

    New York, New York, 10029, United States

  • Rigshospitalet

    Copenhagen, Denmark

  • Solumed

    Poznan, Poland

  • St Mark's Hospital

    Harrow, United Kingdom

  • Szpital Skawina sp. z o.o. im. Stanley Dudricka

    Skawina, Poland

  • The Royal Alexandra Hospital

    Edmonton, Canada

  • UCLH Foundation NHS Trust

    London, United Kingdom

  • UMC Radboud Nijmegen

    Nijmegen, Netherlands

  • UZ Leuven

    Leuven, Belgium

  • University Health Network - Toronto General Hospital

    Toronto, Canada

  • University Hospital Southampton NHS Foundation Trust

    Southampton, United Kingdom

  • University of Chicago Children's Hospital

    Chicago, Illinois, 60637, United States

  • University of East Anglia

    Norwich, United Kingdom

  • University of Nebraska Medical Center

    Omaha, Nebraska, 68198-3285, United States

  • Universitätsklinikum Bonn

    Bonn, 53127, Germany

  • Universitätsklinikum Frankfurt - Med. Klinik I

    Frankfurt, Germany

  • Universitätsmedizin Rostock

    Rostock, Germany

  • Vanderbilt University Medical Center, Nashville

    Nashville, Tennessee, 68198-3285, United States

  • Western University

    London, N6A 4V2, Canada

  • Wojewodzki Specjalistyczny Szpital im. M. Pirogowa w Lodzi

    Lodz, Poland

Conditions

Explore the condition pages connected to this study.